AMFERIA

amferia-logo

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria. Our dominant focus is within the wound care sector, producing preventive care wound patches for the pressing need to avoid antibiotic resistant skin infections. Amferia’s proprietary anti-infective technology is a result of several years of research from Chalmers University of Technology and is patent protected.

#SimilarOrganizations #People #Financial #Website #More

AMFERIA

Social Links:

Industry:
Biotechnology Manufacturing Medical Medical Device

Founded:
2018-01-01

Address:
Mölndal, Vastra Gotaland, Sweden

Country:
Sweden

Website Url:
http://www.amferia.com

Total Employee:
1+

Status:
Active

Total Funding:
6.2 M SEK

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

genetron-health-logo

Genetron Health

Genetron Health is a world-leading expert in precision medicine.

kerecis-logo

Kerecis

Kerecis develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin.

portal-instruments-logo

Portal Instruments

Portal Instruments is an early stage company that offers medical device.

torus-biosystems-logo

Torus Biosystems

Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.

Current Employees Featured

anand-kumar-rajasekharan_image

Anand Kumar Rajasekharan
Anand Kumar Rajasekharan CEO & Co-founder @ Amferia
CEO & Co-founder
2018-09-01

martin-andersson_image

Martin Andersson
Martin Andersson Scientific Advisor & Co-founder @ Amferia
Scientific Advisor & Co-founder

saba-atefyekta_image

Saba Atefyekta
Saba Atefyekta CTO & Co-founder @ Amferia
CTO & Co-founder
2018-10-01

Founder


anand-kumar-rajasekharan_image

Anand Kumar Rajasekharan

martin-andersson_image

Martin Andersson

saba-atefyekta_image

Saba Atefyekta

Investors List

corinthian-properties_image

Corinthian Properties

Corinthian Properties investment in Seed Round - Amferia

chalmers-ventures_image

Chalmers Ventures AB

Chalmers Ventures AB investment in Seed Round - Amferia

alexander-hars_image

Alexander Hars

Alexander Hars investment in Seed Round - Amferia

almi-invest_image

Almi Invest

Almi Invest investment in Seed Round - Amferia

Official Site Inspections

http://www.amferia.com

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Amferia"

Amferia kills bacteria

Amferia’s innovation is protected by three strong patent families. The basic patent is already in force in Europe, the U.S. and China, and pending in several other countries.See details»

Amferia - Company Profile

Amferia is a medical device company combating antibiotic resistance with antimicrobial peptide-hydrogel technology for wound care in human and animal health.See details»

Amferia - Crunchbase Company Profile & Funding

Amferia signed a major contract with Biokema to enter the Swiss market. The company also received €1.2 million in funding to combat resistant bacterial infections. Additionally, Amferia …See details»

Team and board: Meet the team - Amferia

Responsible for Amferia’s wound products for animal care and works at the interface between product development and customer interaction at veterinary clinics across Europe.See details»

Amferia – About

Amferia was born in Gothenburg, Sweden, when three PhD researchers who had been collaborating for five years had the idea to combine their findings. In 2016, after several conversations among themselves, Amferia founders Saba …See details»

Amferia 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Amferia. Use the PitchBook Platform to explore the full profile.See details»

Amferia - Funding, Financials, Valuation & Investors - Crunchbase

Amferia is a startup manufacturing medical materials that actively prevents infections.See details»

Amferia - Contacts, Employees, Board Members, Advisors & Alumni

Amferia is a startup manufacturing medical materials that actively prevents infections.See details»

AMFERIA AB - VentureRadar

"Amferia is a medtech company that develops innovative hydrogel technology to fight antimicrobial resistance. The technology uses antimicrobial peptides to target and destroy …See details»

☑️Amferia — Consulting Organization from Sweden, experience …

Amferia — Consulting Organization from Sweden, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health sectorSee details»

Swedish medtech Amferia snaps €1.2 million to …

Sep 3, 2024 Mölndal-based Amferia, a Swedish medtech company focused on developing innovative antimicrobial healthcare solutions, closed a €1,2 million investment round spearheaded by existing owners and a few new investors, …See details»

Amferia AB, Financial Info, Board and Management, …

Oct 4, 2024 SECTOR Super-Sector: Health CareSector: Health Care Equipment & ServicesSub-Sector: Medical Equipment KEY FIGURES Employees: 5Changes In Board and Management …See details»

Amferia - EU-Startups

Jun 28, 2021 Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia is core focus is preventive healthcare where the goal is to …See details»

Amferia - Chalmers Ventures

Amferia Problem Bacterial infections are likely to surpass cancer and heart disease as a number one cause of human deaths in the future with resistant bacteria and overuse of antibiotics. …See details»

Amferia closes €1,2 million investment to combat resistant …

Sep 3, 2024 Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. During 2024, …See details»

Amferia – Science

Amferia’s hydrogel stabilizes and protects the peptides for up to five days in biological environments, keeping them actively killing bacteria that entire time. Amferia harnesses …See details»

Amferia secures €1.2 million to combat antibiotic-resistant …

Sep 4, 2024 New Delhi: Amferia has completed a €1.2 million investment round aimed at advancing its solutions for bacterial infections. The funding round, which was oversubscribed, …See details»

Amferia closes €1,2 million investment to combat resistant …

Amferia, a Swedish medtech company focused on developing innovative antimicrobial healthcare solutions, announces the successful closure of a 1.2 million euro investment round. The round …See details»

USPTO Grants Patent to Amferia for Antimicrobial Technology

May 10, 2022 Swedish medical device startup Amferia AB has been granted a foundational patent by the US Patent and Trademark Office (USPTO) for an antimicrobial material based …See details»

If Anthropic Succeeds, a Nation of Benevolent AI Geniuses Could …

2 days ago The brother goes on vision quests. The sister is a former English major. Together, they defected from OpenAI, started Anthropic, and built (they say) AI’s most upstanding …See details»

linkstock.net © 2022. All rights reserved